Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics
SYRS Price/Volume Stats
| Current price | $0.20 | 52-week high | $8.17 |
| Prev. close | $0.20 | 52-week low | $0.18 |
| Day low | $0.20 | Volume | 2,841,800 |
| Day high | $0.22 | Avg. volume | 2,361,090 |
| 50-day MA | $1.20 | Dividend yield | N/A |
| 200-day MA | $3.65 | Market Cap | 5.37M |
SYRS Stock Price Chart Interactive Chart >
Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
SYRS Price Returns
| 1-mo | -23.08% |
| 3-mo | -89.74% |
| 6-mo | -96.56% |
| 1-year | -97.16% |
| 3-year | -99.42% |
| 5-year | -99.73% |
| YTD | -97.43% |
| 2023 | 116.99% |
| 2022 | -88.99% |
| 2021 | -69.95% |
| 2020 | 57.02% |
| 2019 | 24.06% |
Continue Researching SYRS
Want to see what other sources are saying about Syros Pharmaceuticals Inc's financials and stock price? Try the links below:Syros Pharmaceuticals Inc (SYRS) Stock Price | Nasdaq
Syros Pharmaceuticals Inc (SYRS) Stock Quote, History and News - Yahoo Finance
Syros Pharmaceuticals Inc (SYRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...